Biogen Inc Stock Technical Analysis
| BIIB Stock | USD 174.12 1.00 0.58% |
As of the 28th of January, Biogen shows the Mean Deviation of 1.39, downside deviation of 1.85, and Risk Adjusted Performance of 0.1117. Biogen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Biogen Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biogen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BiogenBiogen's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Biogen Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 192.14 | Buy | 37 | Odds |
Most Biogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biogen Inc, talking to its executives and customers, or listening to Biogen conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.192 | Earnings Share 10.97 | Revenue Per Share | Quarterly Revenue Growth 0.028 | Return On Assets |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biogen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biogen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biogen.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Biogen on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Biogen Inc or generate 0.0% return on investment in Biogen over 90 days. Biogen is related to or competes with Incyte, Laboratory, Genmab AS, United Therapeutics, Teva Pharma, DexCom, and STERIS Plc. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative di... More
Biogen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biogen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biogen Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.85 | |||
| Information Ratio | 0.1008 | |||
| Maximum Drawdown | 9.61 | |||
| Value At Risk | (2.55) | |||
| Potential Upside | 3.11 |
Biogen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biogen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biogen's standard deviation. In reality, there are many statistical measures that can use Biogen historical prices to predict the future Biogen's volatility.| Risk Adjusted Performance | 0.1117 | |||
| Jensen Alpha | 0.2146 | |||
| Total Risk Alpha | 0.0818 | |||
| Sortino Ratio | 0.1013 | |||
| Treynor Ratio | 0.4242 |
Biogen January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1117 | |||
| Market Risk Adjusted Performance | 0.4342 | |||
| Mean Deviation | 1.39 | |||
| Semi Deviation | 1.64 | |||
| Downside Deviation | 1.85 | |||
| Coefficient Of Variation | 696.75 | |||
| Standard Deviation | 1.86 | |||
| Variance | 3.45 | |||
| Information Ratio | 0.1008 | |||
| Jensen Alpha | 0.2146 | |||
| Total Risk Alpha | 0.0818 | |||
| Sortino Ratio | 0.1013 | |||
| Treynor Ratio | 0.4242 | |||
| Maximum Drawdown | 9.61 | |||
| Value At Risk | (2.55) | |||
| Potential Upside | 3.11 | |||
| Downside Variance | 3.42 | |||
| Semi Variance | 2.7 | |||
| Expected Short fall | (1.49) | |||
| Skewness | (0.11) | |||
| Kurtosis | 0.6488 |
Biogen Inc Backtested Returns
Biogen appears to be very steady, given 3 months investment horizon. Biogen Inc secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Biogen Inc, which you can use to evaluate the volatility of the firm. Please makes use of Biogen's Mean Deviation of 1.39, downside deviation of 1.85, and Risk Adjusted Performance of 0.1117 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Biogen holds a performance score of 11. The firm shows a Beta (market volatility) of 0.6, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Biogen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biogen is expected to be smaller as well. Please check Biogen's maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to make a quick decision on whether Biogen's price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Biogen Inc has no correlation between past and present. Overlapping area represents the amount of predictability between Biogen time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biogen Inc price movement. The serial correlation of 0.0 indicates that just 0.0% of current Biogen price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 33.33 |
Biogen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Biogen Inc Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biogen Inc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Biogen Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biogen Inc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biogen Inc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Biogen Inc price pattern first instead of the macroeconomic environment surrounding Biogen Inc. By analyzing Biogen's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biogen's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biogen specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.00228 | 0.002822 | Price To Sales Ratio | 2.65 | 2.52 |
Biogen January 28, 2026 Technical Indicators
Most technical analysis of Biogen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biogen from various momentum indicators to cycle indicators. When you analyze Biogen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1117 | |||
| Market Risk Adjusted Performance | 0.4342 | |||
| Mean Deviation | 1.39 | |||
| Semi Deviation | 1.64 | |||
| Downside Deviation | 1.85 | |||
| Coefficient Of Variation | 696.75 | |||
| Standard Deviation | 1.86 | |||
| Variance | 3.45 | |||
| Information Ratio | 0.1008 | |||
| Jensen Alpha | 0.2146 | |||
| Total Risk Alpha | 0.0818 | |||
| Sortino Ratio | 0.1013 | |||
| Treynor Ratio | 0.4242 | |||
| Maximum Drawdown | 9.61 | |||
| Value At Risk | (2.55) | |||
| Potential Upside | 3.11 | |||
| Downside Variance | 3.42 | |||
| Semi Variance | 2.7 | |||
| Expected Short fall | (1.49) | |||
| Skewness | (0.11) | |||
| Kurtosis | 0.6488 |
Biogen January 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biogen stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 16,604 | ||
| Daily Balance Of Power | 0.26 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 174.19 | ||
| Day Typical Price | 174.16 | ||
| Price Action Indicator | 0.44 |
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |